REFERENCES
1. Kalehoff JP, Oparil S. The story of the silent killer: a history of hypertension: its discovery, diagnosis, treatment, and debates. Curr Hypertens Rep 2020;22:72.
2. Rahimi K, Bidel Z, Nazarzadeh M, et al. Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. The Lancet 2021;398:1053-64.
3. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021-104.
4. Kobalava ZD, Konradi AO, Nedogoda SV, et al. Arterial hypertension in adults. Clinical guidelines 2020. Russ J Cardiol 2020;25:3786. Available from: https://doi.org/10.15829/1560-4071-2020-3-3786 [Last accessed on 7 Sep 2022].
5. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219.
6. Parati G, Stergiou GS, Bilo G, et al. Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension. J Hypertens 2021;39:1742-67.
7. Muntner P, Carey RM, Jamerson K, Wright JT Jr, Whelton PK. Rationale for ambulatory and home blood pressure monitoring thresholds in the 2017 American college of cardiology/american heart association guideline. Hypertension 2019;73:33-8.
8. Kario K. Blood pressure variability in hypertension: a possible cardiovascular risk factor. Am J Hypertens 2004;17:1075-6.
9. Schutte AE, Kollias A, Stergiou GS. Blood pressure and its variability: classic and novel measurement techniques. Nat Rev Cardiol 2022; doi: 10.1038/s41569-022-00690-0.
10. Kario K. Home blood pressure monitoring: current status and new developments. Am J Hypertens 2021;34:783-94.
11. Doumas M, Tsioufis C, Fletcher R, Amdur R, Faselis C, Papademetriou V. Time in therapeutic range, as a determinant of all-cause mortality in patients with hypertension. J Am Heart Assoc 2017;6:e007131.
12. Fatani N, Dixon DL, Van Tassell BW, Fanikos J, Buckley LF. Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension. J Am Coll Cardiol 2021;77:1290-9.
13. O'Brien E, Parati G, Stergiou G, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. European society of hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013;31:1731-68.
14. Andraos J, Munjy L, Kelly MS. Home blood pressure monitoring to improve hypertension control: a narrative review of international guideline recommendations. Blood Press 2021;30:220-9.
15. Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med 2017;14:e1002389.
16. Park SH, Shin JH, Park J, Choi WS. An updated meta-analysis of remote blood pressure monitoring in urban-dwelling patients with hypertension. Int J Environ Res Public Health 2021;18:10583.
17. Cavero-Redondo I, Saz-Lara A, Sequí-Dominguez I, et al. Comparative effect of eHealth interventions on hypertension management-related outcomes: a network meta-analysis. Int J Nurs Stud 2021;124:104085.
18. Ionov MV, Zhukova OV, Yudina YS, et al. Value-based approach to blood pressure telemonitoring and remote counseling in hypertensive patients. Blood Press 2021;30:20-30.
19. STRIDE BP Scientific Advisory Board. Validated devices for home blood pressure monitoring 2019. Available from: https://stridebp.org/bp-monitors/37-pdfs/734-home?format=pdf&tmpl=component&box=home [Last accessed on 7 Sep 2022].
21. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. The Lancet 2010;375:895-905.
22. Stevens SL, Wood S, Koshiaris C, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ 2016;354:i4098.
23. Zachariah PK, Sheps SG, Ilstrup DM, et al. Blood pressure load - a better determinant of hypertension. Mayo Clinic Proceedings 1988;63:1085-91.
24. Reges O, Ning H, Wilkins JT, et al. Association of cumulative systolic blood pressure with long-term risk of cardiovascular disease and healthy longevity: findings from the lifetime risk pooling project cohorts. Hypertension 2021;77:347-56.
25. Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis 2003;15:213-6.
27. Chung SC, Pujades-Rodriguez M, Duyx B, et al. Time spent at blood pressure target and the risk of death and cardiovascular diseases. PLoS One 2018;13:e0202359.
28. Dixon DL, Baker WL, Buckley LF, Salgado TM, Van Tassell BW, Carter BL. Effect of a physician/pharmacist collaborative care model on time in target range for systolic blood pressure: post hoc analysis of the CAPTION trial. Hypertension 2021;78:966-72.
29. Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA 2013;310:46-56.
30. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briët E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9.
31. Messerli FH, Bangalore S, Messerli AW, Räber L. The muddy waters of the J-curve and coronary revascularization. Eur Heart J 2020;41:1684-6.
32. Bryant KB, Green MB, Shimbo D, et al. Home blood pressure monitoring for hypertension diagnosis by current recommendations: a long way to go. Hypertension 2022;79:e15-7.
33. Omboni S, McManus RJ, Bosworth HB, et al. Evidence and recommendations on the use of telemedicine for the management of arterial hypertension: an international expert position paper. Hypertension 2020;76:1368-83.
34. Omboni S, Padwal RS, Alessa T, et al. The worldwide impact of telemedicine during COVID-19: current evidence and recommendations for the future. Connect Health 2022;1:7-35.
35. Kengne AP, Czernichow S, Huxley R, et al. ADVANCE Collaborative Group. Blood pressure variables and cardiovascular risk: new findings from ADVANCE. Hypertension 2009;54:399-404.
36. Mancia G, Facchetti R, Seravalle G, Cuspidi C, Corrao G, Grassi G. Adding home and/or ambulatory blood pressure to office blood pressure for cardiovascular risk prediction. Hypertension 2021;77:640-9.
37. Parker RA, Paterson M, Padfield P, et al. Are self-reported telemonitored blood pressure readings affected by end-digit preference: a prospective cohort study in Scotland. BMJ Open 2018;8:e019431.
38. Mcmanus RJ, Mant J, Franssen M, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. The Lancet 2018;391:949-59.
